GIACOPPO, DANIELE
 Distribuzione geografica
Continente #
NA - Nord America 1.558
AS - Asia 1.345
EU - Europa 494
SA - Sud America 278
AF - Africa 41
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.719
Nazione #
US - Stati Uniti d'America 1.527
CN - Cina 557
SG - Singapore 466
IT - Italia 282
BR - Brasile 239
KR - Corea 177
UA - Ucraina 58
VN - Vietnam 52
IE - Irlanda 44
RU - Federazione Russa 27
CI - Costa d'Avorio 26
HK - Hong Kong 25
CA - Canada 24
AR - Argentina 16
IN - India 16
BD - Bangladesh 14
FI - Finlandia 12
NL - Olanda 12
AT - Austria 10
GB - Regno Unito 8
ID - Indonesia 8
EC - Ecuador 7
TR - Turchia 7
ZA - Sudafrica 7
ES - Italia 6
SE - Svezia 6
DE - Germania 5
PY - Paraguay 5
CO - Colombia 4
MX - Messico 4
PL - Polonia 4
AZ - Azerbaigian 3
BE - Belgio 3
BY - Bielorussia 3
CH - Svizzera 3
IQ - Iraq 3
MA - Marocco 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BG - Bulgaria 2
EG - Egitto 2
FR - Francia 2
JM - Giamaica 2
JP - Giappone 2
PE - Perù 2
PH - Filippine 2
UZ - Uzbekistan 2
AU - Australia 1
BO - Bolivia 1
CL - Cile 1
CZ - Repubblica Ceca 1
GR - Grecia 1
HN - Honduras 1
IL - Israele 1
JO - Giordania 1
KE - Kenya 1
KI - Kiribati 1
KZ - Kazakistan 1
LB - Libano 1
LT - Lituania 1
MG - Madagascar 1
MK - Macedonia 1
OM - Oman 1
PK - Pakistan 1
QA - Qatar 1
RO - Romania 1
SA - Arabia Saudita 1
SN - Senegal 1
TJ - Tagikistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.719
Città #
Dallas 445
Santa Clara 430
Hefei 351
Singapore 268
Seoul 177
Civitanova Marche 120
Chicago 99
Boardman 73
Jacksonville 64
Dublin 44
Ashburn 39
Catania 38
Chandler 32
Los Angeles 29
Abidjan 26
São Paulo 26
Hong Kong 25
Milan 25
Nanjing 21
Beijing 18
Ho Chi Minh City 17
Andover 13
Rome 13
Cambridge 12
Lawrence 12
Toronto 12
Palermo 11
Brooklyn 9
Hanoi 8
Lappeenranta 8
Moscow 8
San Mateo 8
San Francisco 7
Wilmington 7
Chennai 6
Mascalucia 6
Ottawa 6
Phoenix 6
Rio de Janeiro 6
Curitiba 5
Des Moines 5
Hebei 5
Jiaxing 5
Porto Alegre 5
Shenyang 5
Bernareggio 4
Boston 4
Can Tho 4
Dong Ket 4
Haiphong 4
Helsinki 4
Houston 4
Messina 4
Nanchang 4
Naples 4
Orem 4
Sorocaba 4
Warsaw 4
Washington 4
Agerola 3
Amsterdam 3
Ankara 3
Baku 3
Barcelona 3
Bari 3
Brasília 3
Campinas 3
Contagem 3
Council Bluffs 3
Dhaka 3
Elk Grove Village 3
Itaquaquecetuba 3
London 3
Mauá 3
Mexico City 3
Minsk 3
New York 3
Norwalk 3
Recife 3
Redondo Beach 3
Salvador 3
Salzburg 3
San Cipriano Po 3
Stockholm 3
Tessennano 3
Tianjin 3
Turin 3
Vienna 3
Villafranca Padovana 3
Atlanta 2
Biên Hòa 2
Brussels 2
Buffalo 2
Cape Town 2
Caxias do Sul 2
Charlotte 2
Diadema 2
Durban 2
Florence 2
Guarulhos 2
Totale 2.723
Nome #
Temporal patterns of early neointimal strut coverage of the CATANIA stent compared with drug eluting stents and bare metal stent: the Rapid Evaluation of Vessel Healing after Angioplasty (REVEAL) trial 94
Coronary Angiography, Intravascular Ultrasound, and Optical Coherence Tomography in the Guidance of Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis. 91
Pharmacological and Clinical Appraisal of Factor XI Inhibitor Drugs. 90
Antithrombotic Therapy for Primary and Secondary Prevention of Ischemic Stroke : JACC State-of-the-Art Review 89
Spontaneous coronary artery dissection 79
Treatment strategies for coronary in-stent restenosis: systematic review and hierarchical Bayesian network meta-analysis of 24 randomised trials and 4880 patients. 71
Balancing the Risk of Bleeding and Stroke in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the AVIATOR Registry) 69
Short and mid-term benefits of coronary stent system with nanothin Polyzene-F in acute coronary syndromes: preliminary result 69
Mid-term clinical outcome of Catania coronary stent system with nanothin Polyzene-F in a real world unselected population: preliminary results 69
Meta-Analyses of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation: Do Bleeding and Stent Thrombosis Weigh Similar on Mortality? 68
Safety and effectiveness of the Catania Polyzene-F coated stent in real world clinical practice: 12-month results from the ATLANTA 2 registry 66
PCSK9 inhibitors: current status and emerging frontiers in lipid control 64
Preventive Strategies for Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Procedures: Evidence from a Hierarchical Bayesian Network Meta-Analysis of 124 Trials and 28 240 Patients 63
Usefulness of the logistic clinical SYNTAX score for predicting 1-year mortality in patients undergoing percutaneous coronary intervention of the left main coronary artery 61
Objectifying the impact of incomplete revascularization by repeat angiographic risk assessment with the residual SYNTAX score after left main coronary artery percutaneous coronary intervention. 58
Safety and efficacy of minimalist transcatheter aortic valve implantation using a new-generation balloon-expandable transcatheter heart valve in bicuspid and tricuspid aortic valves. 56
Five-year clinical outcomes in patients with diabetes mellitus treated with polymer-free sirolimus- and probucol-eluting stents versus second-generation zotarolimus-eluting stents: a subgroup analysis of a randomized controlled trial. 55
Characteristics and Impact of Randomized Trials on Drugs or Devices in Cardiovascular Medicine 55
Association between surgical risk and 30‐day stroke after transcatheter versus surgical aortic valve replacement: a systematic review and meta‐analysis. 55
Mid-term clinical outcome of CATANIA Coronary stent system with nanothin Polyzene-F in a real world unselected population: preliminary results 55
Meta-analysis of Randomized Controlled Trials of Preprocedural Statin Administration for Reducing Contrast Induced Acute Kidney In Patients Undergoing Coronary Catheterization 55
Drug-coated balloon angioplasty for in-stent restenosis of femoropopliteal arteries: a meta-analysis 54
Coronary artery restenosis treatment with plain balloon, drug-coated balloon, or drug-eluting stent: 10-year outcomes of the ISAR-DESIRE 3 trial 54
Five‐year follow‐up of polymer‐free sirolimus‐ and probucol‐eluting stents versus new generation zotarolimus‐eluting stents in patients presenting with st‐elevation myocardial infarction 52
Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation in Patients With Coronary Stent Restenosis. 52
Applied coronary physiology for planning and guidance of percutaneous coronary interventions. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the European Society of Cardiology. 52
Management of in-stent restenosis 51
Coronary Drug-Coated Balloons for De Novo and In-Stent Restenosis Indications. 50
Current developments in dual antiplatelet therapy after stenting 50
Anticoagulation After Transcatheter Aortic Valve Replacement 50
Changes in high-sensitivity troponin after drug-coated balloon angioplasty for drug-eluting stent restenosis. 50
Evaluation of a Low-Dose Radiation Protocol During Transcatheter Aortic Valve Implantation 49
Meta-Analysis of Short vs. Prolonged Dual Antiplatelet Therapy after Drug-Eluting Stent Implantation and Role of Continuation with either Aspirin or a P2Y12 Inhibitor Thereafter 49
Lipoprotein(a) as a Pharmacological Target: Premises, Promises, and Prospects 49
Do outcomes following intervention for drug-eluting stent restenosis depend on whether the restenosed stent was polymer-free or polymer-coated? 49
Effects on Mortality and Major Bleeding of Radial Versus Femoral Artery Access for Coronary Angiography or Percutaneous Coronary Intervention: Meta-Analysis of Individual Patient Data From 7 Multicenter Randomized Clinical Trials. 48
Short dual antiplatelet therapy followed by P2Y12 inhibitor monotherapy vs. prolonged dual antiplatelet therapy after percutaneous coronary intervention with second-generation drug-eluting stents: a systematic review and meta-analysis of randomized clinical trials 47
Acute kidney injury after endovascular interventions for critical limb ischemia: Is that a whole different animal? 47
Outcomes of patients treated with durable polymer platinum-chromium everolimus-eluting stents: a meta-analysis of randomised trials. 47
Vascular response to percutaneous coronary intervention with biodegradable-polymer vs. new-generation durable-polymer drug-eluting stents: a meta-analysis of optical coherence tomography imaging trials 46
Intraindividual Comparison of Everolimus-Eluting Bioresorbable Vascular Scaffolds Versus Drug-Eluting Metallic Stents 46
Management of myocardial revascularisation failure: an expert consensus document of the EAPCI 45
The Rapid Evaluation of Vessel Healing after Angioplasty (REVEAL) trial 44
Should we routinely use ultrasound-guided transfemoral access for coronary procedures? High-quality evidence from an individual participant data meta-analysis. 44
Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting in Patients With Left Main Coronary Artery Stenosis. 44
Paclitaxel-coated balloon angioplasty vs. drug-eluting stenting for the treatment of coronary in-stent restenosis: a comprehensive, collaborative, individual patient data meta-analysis of 10 randomized clinical trials (DAEDALUS study). 44
Validation of the DAPT score in patients randomized to 6 or 12 months clopidogrel after predominantly second-generation drug-eluting stents. 44
Response by Giacoppo et al to Letter Regarding Article “Coronary Angiography, Intravascular Ultrasound, and Optical Coherence Tomography for Guiding of Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis” 43
Transcatheter versus surgical aortic valve replacement in the digital era: Meta‐analysis based on the reconstruction of time‐to‐event individual patient data. 43
Optimal periprocedural antithrombotic therapy in percutaneous coronary intervention: Between a rock and a hard place? 42
Risk of stroke, atrial fibrillation, and major bleeding after mitral valve repair: the jury is still out. 41
Transcatheter aortic valve replacement for bicuspid aortic valve stenosis with first- and new-generation bioprostheses: A systematic review and meta-analysis. 41
A pairwise and network meta-analysis of anti-inflammatory strategies after myocardial infarction: the TITIAN study 40
Incidence and impact of acute kidney injury in patients with acute coronary syndromes treated with coronary artery bypass grafting: Insights from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) and Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trials 39
Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents. 38
Dual antiplatelet therapy de-escalation by discontinuation in patients with ST-segment elevation myocardial infarction: a systematic review and meta-analysis 37
Changes in Coagulation Factor XI Activity Levels in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary PCI 36
Prognostic Value of Cardiac Troponin T and Sex in Patients Undergoing Elective Percutaneous Coronary Intervention 36
Koronare Herzerkrankung mit Hauptstammbeteiliung 35
P2Y 12 inhibitor or aspirin after percutaneous coronary intervention: individual patient data meta-analysis of randomised clinical trials 34
Current Management of In-Stent Restenosis 34
Antiplatelet Therapy in Patients Requiring Oral Anticoagulation and Undergoing Percutaneous Coronary Intervention 33
Impact of stent size on angiographic and clinical outcomes after implantation of everolimus-eluting bioresorbable scaffolds in daily practice: insights from the ISAR-ABSORB registry 32
One-month DAPT after biodegradable-polymer everolimus-eluting stent implantation in patients at high-bleeding risk: an individual patient data pooled analysis of the SENIOR and POEM trials 31
Drug-Coated Balloon Versus Plain Balloon Angioplasty for the Treatment of Femoropopliteal Artery Disease. 31
Angiographic and clinical outcomes of patients treated with drug-coated balloon angioplasty for in-stent restenosis after coronary bifurcation stenting with a two-stent technique. 30
Long-term effectiveness and safety of transcatheter closure of patent foramen ovale compared with antithrombotic therapy alone: a meta-analysis of six randomised clinical trials and 3,560 patients with reconstructed time-to-event data 30
Untangling the knot of the best endovascular treatment for femoropopliteal artery disease 29
Trends in transcatheter aortic valve implantation practice and clinical outcomes at an Irish tertiary referral centre 29
Paclitaxel- or sirolimus-coated balloons for coronary bifurcations: is the side branch SPACIOUS enough for both? 28
Management of Patients Treated With Oral Anticoagulant Therapy Undergoing Percutaneous Coronary Intervention With Stent Implantation: The PERSEO Registry 27
Completeness, timing, and guidance of percutaneous coronary intervention for myocardial infarction and multivessel disease: a systematic review and network meta-analysis 27
Predicting the risk of in-stent restenosis after drug-eluting stent implantation: Pipe dream or machine learning-enabled opportunity? 26
Expanding indications for drug-coated balloons in coronary artery disease 25
Gli stent coronarici a rilascio di farmaco nella pratica interventistica contemporanea: progetto STENT PANORAMA (Parte I) 23
Reply: Completeness or complexity? A nuanced reflection on multivessel revascularisation 22
Radial artery access among mainstays of contemporary percutaneous coronary intervention: Is it time to forget how to puncture a femoral artery? 21
Impact of bystander-initiated cardiopulmonary resuscitation for out-of-hospital cardiac arrest: where would you be happy to have a cardiac arrest? 20
Off TARGET Effects in Stent Comparison Trials 20
Long-Term Antithrombotic Therapy in Patients with Atrial Fibrillation and Percutaneous Coronary Intervention 20
Prasugrel monotherapy versus standard DAPT in STEMI patients with OCT-guided or angio-guided complete revascularisation: design and rationale of the randomised, multifactorial COMPARE STEMI ONE trial 20
Molecular multimodality imaging: has a long-standing dream come true? 19
Individual patient data meta-analysis of paclitaxel-coated balloons vs. drug-eluting stents for small-vessel coronary artery disease: the ANDROMEDA study 18
High-risk percutaneous coronary intervention in patients with reduced left ventricular ejection fraction deemed not suitable for surgical revascularisation. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) in collaboration with the ESC Working Group on Cardiovascular Surgery 13
Targeting Inflammation After Acute Myocardial Infarction 9
Advances in the Detection and Management of Vulnerable Coronary Plaques 5
Anti-inflammatory pharmacotherapy in patients with cardiovascular disease 5
Totale 3.821
Categoria #
all - tutte 12.856
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.856


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202158 0 0 0 1 21 0 12 0 8 0 12 4
2021/202290 12 13 1 0 16 0 13 6 10 0 2 17
2022/2023127 12 1 1 9 20 21 0 18 40 1 0 4
2023/2024246 1 14 4 14 1 10 0 70 12 14 63 43
2024/20251.483 16 174 53 137 328 200 72 30 99 105 92 177
2025/20261.682 350 595 542 195 0 0 0 0 0 0 0 0
Totale 3.821